Avidas Pharmaceuticals, LLC, a privately held, specialty pharmaceutical company which focuses on dermatology, women's health and endocrinology, announced that it has acquired North American rights to several prescription and OTC dermatology products from Crown Laboratories, Inc. This agreement expands Avidas' dermatology franchise and adds products that address chronic dermatologic conditions including scalp psoriasis and seborrheic dermatitis, disorders which afflict in excess of 15 million people in the U.S.
The first products to be launched by Avidas from this acquisition will be Scalacort, a prescription corticosteroid for the relief of inflammatory and pruritic...
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry